13F Holdings
中文EN

SBC SBC Medical Group Holdings Inc

Services-Offices & Clinics of Doctors of Medicine · Nasdaq · SEC CIK 1930313 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.7%
TTM net income YoY19.8%
TTM EPS YoY21.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin72.2%
Operating margin39.9%
Net margin27.3%
FCF margin52.6%
EBITDA margin41.1%

Returns

ROE19.4%
ROA13.9%
ROIC (approx.)37.5%
Asset turnover0.51x

Leverage & solvency

Liabilities / assets28.6%
Debt / equity0.12x
Current ratio3.67x
Interest coverage181.93x

Cash quality & payout

Operating cash flow / net income1.97x
Accruals ratio-13.5%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue$173.61M$205.42M$193.54M
Cost of revenue$46.32M$49.37M$56.24M
Gross profit$127.28M$156.05M$137.30M
SG&A expense$59.80M$57.67M$66.23M
Operating income$67.49M$70.30M$70.66M
Interest expense$148,238$28,300$45,292
Pretax income$82.07M$73.46M$73.58M
Income tax$31.02M$26.77M$35.02M
Net income$50.99M$46.61M$39.37M
EBITDA$70.17M$74.10M$82.91M
EPS (basic)0.500.480.42
EPS (diluted)0.500.480.42
Weighted avg. shares (diluted)103.00M96.56M94.19M
Balance sheet
Cash & equivalents$163.77M$125.04M$103.02M
Short-term investments$319,193$0—
Inventory$2.79M$1.49M$3.09M
Current assets$231.22M$184.45M$165.91M
PP&E, net$7.54M$8.77M$13.58M
Goodwill$15.43M$4.61M$3.59M
Intangibles$47.74M$1.59M$19.74M
Total assets$380.45M$266.08M$258.81M
Current liabilities$61.12M$61.19M$92.45M
Short-term debt$228,210$262,095$329,155
Long-term debt$42.83M$6.60M—
Total debt$43.06M$6.86M—
Total liabilities$117.14M$71.06M$115.00M
Shareholders' equity$248.28M$195.11M$142.16M
Net debt-$120.71M-$118.18M—
Shares outstanding102.58M102.75M94.19M
Cash flow statement
Operating cash flow$24.67M$20.58M$50.67M
Capital expenditure$1.40M$2.56M$8.54M
Free cash flow$23.27M$18.02M$42.13M
Investing cash flow-$20.97M-$10.10M$1.79M
Financing cash flow$38.29M$22.97M$6.14M
Depreciation & amortization$2.68M$3.80M$12.25M
Stock-based compensation$0$13.02M—
Share buybacks$5.00M$0—

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.